<DOC>
	<DOCNO>NCT00250666</DOCNO>
	<brief_summary>The current study aim validate diagnostic use PCT assess capability individualize shorten duration antibiotic therapy critically ill patient suspect confirmed sepsis . In particular , well-designed intervention study properly examine follow hypothesis : A PCT-guided antibiotic discontinuation strategy enable reduce antibiotic treatment duration critically ill patient suspect documented sepsis , without harm patient safety .</brief_summary>
	<brief_title>Procalcitonin-Guided Antimicrobial Discontinuation</brief_title>
	<detailed_description>Primary objective : To assess effect repeat PCT measurement critically ill patient clinically suspect microbiologically document sepsis duration antimicrobial use compare strategy standard clinical practice , use improve PCT assay sensitivity 0.06 ng/ml . Secondary objective : To determine impact repeat PCT measurement patient outcome ( morbidity , mortality , emergence antibiotic resistance nosocomial super-infections ) . Main measure : Primary : 1 . Exposure systemic antimicrobial treatment ( duration antibiotic treatment total antibiotic exposure ) Secondary : 2 . Cure failure rate infection ( N recurrent infection per 100 patient ) 3 . 28-day case-fatality rate ( N death per 100 patient ) 4 . Length hospital stay ( day ) 5 . Costs antimicrobial therapy ( CHF ) 6 . Rate nosocomial super-infection ( N super-infections per 100 patient ) 7 . Isolation multi-resistant microorganism ( clinical isolates per 100 patient-days )</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>1 . Patients clinically suspect microbiologically confirm bacterial sepsis 2 . Informed consent 1 . Patients microbiologically documented infection cause follow microorganism : Listeria spp , Legionella pneumophilia , Mycobacterium tuberculosis , Staphylococcus aureus 2 . Patients fungal infection 3 . Patients severe infection due virus parasite ( e.g . hemorrhagic fever , malaria ) 4 . Patients suspect confirmed bacterial meningitis endocarditis 5 . Patients localize , deepseated abscess ( e.g . brain abscess ) without systemic sepsis 6 . Patients chronic , localized infection ( e.g . chronic osteomyelitis ) without systemic sepsis 7 . Neutropenic severely immunocompromised patient ( patient infect human immunodeficiency virus CD4 count &lt; 200 ; patient immunosuppressive therapy solid organ transplantation ; patient cystic fibrosis ) 8 . Withholding lifesupport 9 . Early discharge death ( &lt; 24 hour admission ) 10 . Complete absence antimicrobial treatment despite suspicion sepsis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Biological Markers</keyword>
	<keyword>Procalcitonin</keyword>
	<keyword>Critical Care</keyword>
	<keyword>Diagnosis , Differential</keyword>
	<keyword>Prospective Study</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Antibiotic stewardship</keyword>
	<keyword>Antimicrobial resistance</keyword>
</DOC>